These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12971592)

  • 1. Fixed low-dose combination therapy: current recommendations.
    Prisant LM
    Manag Care; 2003 Aug; 12(8 Suppl Hypertension):45-50. PubMed ID: 12971592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension: a multietiological disease requires a multifactorial approach.
    Trotman BW
    J Assoc Acad Minor Phys; 1995; 6(4):124. PubMed ID: 8520174
    [No Abstract]   [Full Text] [Related]  

  • 3. Racial differences in medication compliance and healthcare utilization among hypertensive Medicaid recipients: fixed-dose vs free-combination treatment.
    Dickson M; Plauschinat CA
    Ethn Dis; 2008; 18(2):204-9. PubMed ID: 18507275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of compliance with antihypertensive therapy in a high-risk medicaid population.
    Shaya FT; Du D; Gbarayor CM; Frech-Tamas F; Lau H; Weir MR
    J Natl Med Assoc; 2009 Jan; 101(1):34-9. PubMed ID: 19245070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed-dose triple-combination treatments in the management of hypertension.
    Ram CV
    Manag Care; 2013 Dec; 22(12):45-55. PubMed ID: 24555265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of ACE Inhibitors and ARBs in Black Patients With Hypertension.
    Helmer A; Slater N; Smithgall S
    Ann Pharmacother; 2018 Nov; 52(11):1143-1151. PubMed ID: 29808707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension.
    Ferdinand KC; Bakris GL; Cushman WC; Weber MA; Lloyd E; Wu J; White WB
    Am J Cardiol; 2018 Nov; 122(9):1496-1505. PubMed ID: 30217371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
    Everett BM; Glynn RJ; Danielson E; Ridker PM;
    Clin Ther; 2008 Apr; 30(4):661-72. PubMed ID: 18498915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should drug treatment be started with monotherapy or combination therapy for patients with hypertension].
    Kato J; Eto T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():254-7. PubMed ID: 16983767
    [No Abstract]   [Full Text] [Related]  

  • 10. Using fixed-dose combination therapies to achieve blood pressure goals.
    Chrysant SG
    Clin Drug Investig; 2008; 28(11):713-34. PubMed ID: 18840014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
    Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
    JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI).
    Jones D; Basile J; Cushman W; Egan B; Ferrario C; Hill M; Lackland D; Mensah G; Moore M; Ofili E; Roccella EJ; Smith R; Taylor H
    Am J Med Sci; 1999 Dec; 318(6):357-64. PubMed ID: 10616159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing patterns in the treatment of hypertension among underserved African American elderly.
    Yazdanshenas H; Bazargan M; Orum G; Loni L; Mahabadi N; Husaini B
    Ethn Dis; 2014; 24(4):431-7. PubMed ID: 25417425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Module 3: Using thiazide-type diuretics in African Americans with hypertension.
    Wright JT
    J Fam Pract; 2012 Aug; 61(8 Suppl):S20-2; quiz S31. PubMed ID: 22993738
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertension: a review of therapeutic options.
    Carter BL
    Manag Care; 2003 Aug; 12(8 Suppl Hypertension):34-44. PubMed ID: 12971591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical inquiries. What is the best treatment for hypertension in African Americans?
    Rao S; Cherukuri M; Mayo HG; Sehgal M
    J Fam Pract; 2007 Feb; 56(2):149-51. PubMed ID: 17270125
    [No Abstract]   [Full Text] [Related]  

  • 17. Discrepant antihypertensive dose recommendations.
    Milic M; Ziegler MG
    Clin Exp Hypertens; 2006 Feb; 28(2):171-80. PubMed ID: 16546842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of the Use of Clinical-Guideline-Recommended Antihypertensive Regimens in Mexican American, Non-Hispanic Black, and Non-Hispanic White Adults With Type 2 Diabetes and Hypertension in the United States: NHANES 2003-2012.
    Perez A; Levin A; Alam N
    Diabetes Educ; 2016 Dec; 42(6):739-747. PubMed ID: 27621092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed low-dose combination in first-line treatment of hypertension.
    Prisant LM
    J Hypertens Suppl; 2002 Feb; 20(1):S11-9. PubMed ID: 11996195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy in hypertension: an Asia-Pacific consensus viewpoint.
    Abdul Rahman AR; Reyes EB; Sritara P; Pancholia A; Van Phuoc D; Tomlinson B
    Curr Med Res Opin; 2015 May; 31(5):865-74. PubMed ID: 25707364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.